Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Mercier

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Plos One|May 30, 2020
Therapeutically-induced stable disease in oncology early clinical trialsFrancois Mercier, Georgina Meneses-Lorente, Paul Grimsey, et al.
Clinical Pharmacokinetics|March 12, 2021
Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIIIFredrik Jonsson, Christophe Schmitt, Claire Petry, et al.
Cancer Chemotherapy and Pharmacology|July 23, 2015
Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patientsLaurent Claret, Francois Mercier, Brett E Houk, et al.
Journal of Clinical Pharmacology|November 24, 2011
Population pharmacokinetics of fingolimod phosphate in healthy participantsKai Wu, Francois Mercier, Olivier J David, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 1, 2020
Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatmentFrancois Mercier, Marion Kerioui, Solène Desmée, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2022
Efficacy and safety exposure-response analyses of entrectinib in patients with advanced or metastatic solid tumorsFrancois Mercier, Nassim Djebli, Mario González-Sales, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2020
Assessing the translational value of pre-clinical studies for clinical response rate in oncology: an exploratory investigation of 42 FDA-approved small-molecule targeted anticancer drugsWenying Angela Liu, Li Yu, Peter N Morcos, et al.
Statistical Methods in Medical Research|November 15, 2023
Estimating drug concentration-response relationships by applying causal inference methods for continuous point exposures and time-to-event outcomesSean Yiu, Qing Wang, Francois Mercier, et al.
Statistics in Medicine|October 8, 2020
Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapyMarion Kerioui, Francois Mercier, Julie Bertrand, et al.
Journal of Environmental Radioactivity|December 30, 2015
The determination of Fukushima-derived cesium-134 and cesium-137 in Japanese green tea samples and their distribution subsequent to simulated beverage preparationMatthew C Cook, Matthew J Stukel, Weihua Zhang, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Plos One|May 30, 2020
Therapeutically-induced stable disease in oncology early clinical trialsFrancois Mercier, Georgina Meneses-Lorente, Paul Grimsey, et al.
Clinical Pharmacokinetics|March 12, 2021
Exposure-Bleeding Count Modeling of Emicizumab for the Prophylaxis of Bleeding in Persons with Hemophilia A with/Without Inhibitors Against Factor VIIIFredrik Jonsson, Christophe Schmitt, Claire Petry, et al.
Cancer Chemotherapy and Pharmacology|July 23, 2015
Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patientsLaurent Claret, Francois Mercier, Brett E Houk, et al.
Journal of Clinical Pharmacology|November 24, 2011
Population pharmacokinetics of fingolimod phosphate in healthy participantsKai Wu, Francois Mercier, Olivier J David, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 1, 2020
Longitudinal analysis of organ-specific tumor lesion sizes in metastatic colorectal cancer patients receiving first line standard chemotherapy in combination with anti-angiogenic treatmentFrancois Mercier, Marion Kerioui, Solène Desmée, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2022
Efficacy and safety exposure-response analyses of entrectinib in patients with advanced or metastatic solid tumorsFrancois Mercier, Nassim Djebli, Mario González-Sales, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2020
Assessing the translational value of pre-clinical studies for clinical response rate in oncology: an exploratory investigation of 42 FDA-approved small-molecule targeted anticancer drugsWenying Angela Liu, Li Yu, Peter N Morcos, et al.
Statistical Methods in Medical Research|November 15, 2023
Estimating drug concentration-response relationships by applying causal inference methods for continuous point exposures and time-to-event outcomesSean Yiu, Qing Wang, Francois Mercier, et al.
Statistics in Medicine|October 8, 2020
Bayesian inference using Hamiltonian Monte-Carlo algorithm for nonlinear joint modeling in the context of cancer immunotherapyMarion Kerioui, Francois Mercier, Julie Bertrand, et al.
Journal of Environmental Radioactivity|December 30, 2015
The determination of Fukushima-derived cesium-134 and cesium-137 in Japanese green tea samples and their distribution subsequent to simulated beverage preparationMatthew C Cook, Matthew J Stukel, Weihua Zhang, et al.
Pageof 5